about
Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)Predicting cell types and genetic variations contributing to disease by combining GWAS and epigenetic dataThe development and application of a quantitative peptide microarray based approach to protein interaction domain specificity spaceIEDB-3D: structural data within the immune epitope databaseNovel sequence feature variant type analysis of the HLA genetic association in systemic sclerosisPre-existing immunity against swine-origin H1N1 influenza viruses in the general human populationAutomating document classification for the Immune Epitope DatabaseThe immune epitope database and analysis resource: from vision to blueprintAn ontology for immune epitopes: application to the design of a broad scope database of immune reactivities.Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method.New strategies for allergen T cell epitope identification: going beyond IgEA Protective Role for Dengue Virus-Specific CD8+ T CellsClassification of the Universe of Immune Epitope Literature: Representation and Knowledge GapsStructural and Biochemical Characterization of the Vaccinia Virus Envelope Protein D8 and Its Recognition by the Antibody LA5Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoirePotent Neutralization of Vaccinia Virus by Divergent Murine Antibodies Targeting a Common Site of Vulnerability in L1 ProteinAnalysis of Human RSV Immunity at the Molecular Level: Learning from the Past and PresentIdentifying Candidate Targets of Immune Responses in Zika Virus Based on Homology to Epitopes in Other Flavivirus SpeciesModeling biomedical experimental processes with OBIA population response analysis approach to assign class II HLA-epitope restrictionsNetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequenceAbacavir-reactive memory T cells are present in drug naïve individualsAcyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity.The Ontology for Biomedical InvestigationsCLO: The cell line ontologyPatterns of cellular immunity associated with experimental infection with rDEN2Δ30 (Tonga/74) supports its suitability as a human DENV challenge strainHuman CD4+ T cell responses to an attenuated tetravalent dengue vaccine parallel those induced by natural infection, in magnitude, HLA restriction and antigen specificityQuantitating T cell cross-reactivity for unrelated peptide antigensIMMUNOCAT-a data management system for epitope mapping studiesPeptide-binding motifs of two common equine class I MHC molecules in Thoroughbred horsesThe common equine class I molecule Eqca-1*00101 (ELA-A3.1) is characterized by narrow peptide binding and T cell epitope repertoires.ElliPro: a new structure-based tool for the prediction of antibody epitopesImmune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.Pro-apoptotic Bax molecules densely populate the edges of membrane pores.Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine DesignStrategies to query and display allergy-derived epitope data from the immune epitope database.A molecular view of multiple sclerosis and experimental autoimmune encephalitis: what can we learn from the epitope data?Navigating diabetes-related immune epitope data: resources and tools provided by the Immune Epitope Database (IEDB)Derivation of an amino acid similarity matrix for peptide: MHC binding and its application as a Bayesian prior.
P50
Q21034050-1E072E85-A28A-4F2A-9785-19D513E850C0Q21133752-F3E01FDE-BD63-4266-8DDA-D8CC12EDDDB6Q24563332-8F65FD69-14C5-456D-A772-F88235636D0DQ24608976-FDE9D440-5715-4A4D-A7EA-EAB0D1078419Q24645988-FFC4F5AD-52C9-4CFA-85A9-34900AD561CCQ24655857-A112BB05-E588-426D-9EC9-3A08C25B91B0Q24670032-052FFD6B-422C-4F53-86D3-7DE3DED6BACBQ24804461-7B3CBCA1-4D73-4F8D-A362-88E262DE51BEQ24810967-6693171E-7959-4281-856A-D74C2A9B8E68Q24815448-711B67B9-09AF-4BE3-AA3F-5F44C25821D0Q26824787-C5B5D1FD-D2AB-46B8-8346-419948B2954CQ27488347-A01B802A-9F90-413F-B5C9-D9BFDE45A500Q27489679-2BB91B1D-C28A-4A7F-81E8-DBA0B2B2A508Q27679281-AC7CFF78-E514-4E1E-9B21-C7933C3DBC27Q27679355-586463ED-F0C4-4518-92E6-5101E6BA4114Q27684713-0B368780-2F1B-4D12-A66C-D8BC68A87D66Q28080556-6F9C55CC-BBC6-47F2-A385-57EF86C1599BQ28119651-7E80A421-6C7D-43CE-BE54-1A53858FA973Q28287823-537AEF2D-F934-4B07-A1F7-32B74FA2CC3BQ28395866-D137A83B-D38D-47A4-9AD6-5A0C322C2841Q28469279-5EBF6936-FF19-433A-B5E8-B13324E0DBF7Q28543405-80701FE8-2819-4C2A-A1BA-91AD9BFECDA5Q28547607-9620C822-9F53-49B5-B32E-03ADEC2AC42BQ28551680-A205931A-61E8-4B1B-82EA-DCC2B2672DD5Q28650204-2573DF1F-70BD-41EE-9A28-2B874CC9AB39Q28729784-603A9A81-1970-42A8-A5B0-D26A365AB32DQ28733418-B295DE25-C5CD-4B7B-968A-00B2FBD0C333Q28750512-5676870C-E919-41F5-B675-95C9331DE2CAQ28752157-6D508973-11DE-40BB-B3FF-EE177680E00EQ30252926-156D16DB-ED14-4124-8152-086B145C5C79Q30278636-A2B9517B-AE4E-4D55-B93F-351326453937Q30373719-A2F74093-CB3B-4BFB-A4CD-1CB8D35B80A9Q30381864-2D898DD4-4C01-47F9-90B1-FBAA96C88CD9Q30388868-DA371CF4-A708-4477-91B3-C8291EA2540FQ30398403-82419E47-EAA8-41C8-83DF-123EB94CE1B3Q30400430-FC5DB8BF-EF47-4CA6-B737-87706A34BF3DQ30578181-2D87E9EA-0977-429C-A90F-253F6B4C8171Q30723942-0EF2D118-44A0-4975-AF58-5CCE21F01204Q30843737-B1AF06F2-4AAD-40C6-AE85-93AC98422350Q30932156-95A422B1-CBFD-4A42-A322-4078EA114E68
P50
description
researcher ORCID ID = 0000-0002-8457-6693
@en
wetenschapper
@nl
name
Bjoern Peters
@ast
Bjoern Peters
@en
Bjoern Peters
@es
Bjoern Peters
@nl
type
label
Bjoern Peters
@ast
Bjoern Peters
@en
Bjoern Peters
@es
Bjoern Peters
@nl
prefLabel
Bjoern Peters
@ast
Bjoern Peters
@en
Bjoern Peters
@es
Bjoern Peters
@nl
P108
P21
P31
P496
0000-0002-8457-6693